<DOC>
	<DOCNO>NCT01737983</DOCNO>
	<brief_summary>The purpose study evaluate patient cystic fibrosis effect Lactobacillus Reuteri ( LR ) rate respiratory exacerbation infection upper respiratory gastrointestinal tract .</brief_summary>
	<brief_title>Effect Lactobacillus Reuteri Cystic Fibrosis</brief_title>
	<detailed_description>The hallmark cystic fibrosis ( CF ) recurrent severe destructive pulmonary inflammation infection , begin early childhood lead morbidity mortality due respiratory failure . During disease , child become colonized Pseudomonas aeruginosa ( PA ) undergo progressive impairment respiratory function . Therefore , patient colonize Pseudomonas increase risk pulmonary infection persistent inflammation decrease survival rate . In attempt reduce rate severity pulmonary exacerbation , child CF put heavy load antibiotic . Intestinal inflammation another typical finding CF patient gut bacterial overgrowth may present . Probiotics live bacteria administer orally , successfully used child acute gastroenteritis , well prevent treat atopic disease child . In addition , probiotic use adjuvant therapy patient pouchitis inflammatory bowel disease . Interestingly , probiotic supplementation able reduce incidence fever , child care absence , antibiotic prescription prevent nosocomial gastrointestinal respiratory infection . The effect probiotic may improvement intestinal barrier function modulation immune response . The latter mechanism could well explain clinical effect probiotic observe extraintestinal disease .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>Forced expiratory volume 1st second ( FEV1 ) &gt; 70 % . No inhaled systemic steroid . No antiinflammatory drug , antileukotrienes mast cell membrane stabilizer . No serious organ involvement . History pulmonary exacerbation upper respiratory infection previous two month . Changes medication past two month . History hemoptysis past two month .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>probiotic</keyword>
	<keyword>Lactobacillus reuteri</keyword>
</DOC>